IU School of Medicine is awaiting results of two clinical trials for the drug remdesivir as they study potential treatments for COVID-19.
One trial focused on patients who need supplemental oxygen. Researchers are studying if a five-day remdesivir treatment worked as well as a ten-day treatment. The second trial studied the impact of remdesivir on hospital patients who didn’t require supplemental oxygen.
Other trials of the drug have shown some positive results, giving hope to many that the virus is treatable.
“It may very well be similar to other infectious diseases where we know that certain therapies are important for people early, and then certain therapies are more important later, or maybe you combine the treatments.”Dr. Samir Gupta, Vice Chair for Research, Department of Medicine, Indiana University School of Medicine
Both trials have been completed and results are expected to be back by the end of May.